COVID-19 复发病例报告。
Case Reports of COVID 19 Recurrence.
机构信息
Miami Veterans Administration Medical Center,University of Miami, Miami, FL, USA.
出版信息
J Prim Care Community Health. 2021 Jan-Dec;12:2150132720982752. doi: 10.1177/2150132720982752.
Abstract
CASE REPORT OF COVID 19-Recurrence We describe as case series of 7 patients who presented with a recurrence of COVID 19 by PCR test an average of 94.9 days after their initial symptomatic presentation of illness. Patients had tested negative by PCR or had evidence of antibodies in between the 2 episodes. The majority of patients were asymptomatic on the second presentation and were found incidentally on prescreen for procedures, surgery. The subsequent positive COVID-19 PCR tests resulted in cancellations of clinic, procedures, surgery, and impacted patients' home and employment status. Further studies are needed to understand the mechanisms and ultimate outcomes of these recurrences.
摘要
COVID-19 复发病例报告
我们描述了 7 例患者的病例系列，这些患者在最初出现症状后平均 94.9 天通过 PCR 检测呈 COVID-19 复发。两次发作之间，患者的 PCR 检测结果为阴性或有抗体证据。大多数患者第二次就诊时无症状，是在为程序、手术进行预筛查时偶然发现的。随后 COVID-19 PCR 检测呈阳性，导致取消门诊、程序、手术，并影响了患者的家庭和就业状况。需要进一步研究以了解这些复发的机制和最终结果。
相似文献
1
Case Reports of COVID 19 Recurrence.COVID-19 复发病例报告。
J Prim Care Community Health. 2021 Jan-Dec;12:2150132720982752. doi: 10.1177/2150132720982752.
2
Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19.COVID-19 患者痊愈后 RT-PCR 结果阳性者病毒载量和抗 SARS-CoV-2 抗体的动态变化。
Korean J Intern Med. 2021 Jan;36(1):11-14. doi: 10.3904/kjim.2020.325. Epub 2020 Nov 25.
3
Reinfection, recurrence, or delayed presentation of COVID-19? Case series and review of the literature.再感染、复发还是 COVID-19 的延迟表现？病例系列和文献复习。
J Infect Public Health. 2021 Apr;14(4):474-477. doi: 10.1016/j.jiph.2021.01.002. Epub 2021 Jan 14.
4
Severe, Symptomatic Reinfection in a Patient with COVID-19.一名新冠肺炎患者发生严重的有症状再感染
R I Med J (2013). 2020 Nov 9;103(10):24-26.
5
COVID-19 reinfections.COVID-19 再感染。
Epidemiol Mikrobiol Imunol. 2021 Spring;70(1):62-67.
6
Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.巴西 30 名医护人员出现反复感染 COVID-19 现象，且病情加重。
J Infect. 2021 Mar;82(3):399-406. doi: 10.1016/j.jinf.2021.01.020. Epub 2021 Feb 13.
7
Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case report from Brazil.巴西的一例报告：SARS-CoV-2 再感染和新冠复发是否可能？
Rev Soc Bras Med Trop. 2020 Sep 18;53:e20200619. doi: 10.1590/0037-8682-0619-2020. eCollection 2020.
8
Incidence of delayed asymptomatic COVID-19 recurrences in a 6-month longitudinal study.一项为期6个月的纵向研究中无症状新冠病毒感染延迟复发的发生率。
J Infect. 2021 Jun;82(6):276-316. doi: 10.1016/j.jinf.2021.03.020. Epub 2021 Mar 29.
9
Reinfection of SARS-CoV-2 - analysis of 23 cases from the literature.SARS-CoV-2 再感染 - 文献中 23 例分析。
Infect Dis (Lond). 2021 Jul;53(7):479-485. doi: 10.1080/23744235.2021.1905174. Epub 2021 Apr 13.
10
Recurrence of SARS-CoV-2 nucleic acid positive test in patients with COVID-19: a report of two cases.新冠病毒感染者核酸复阳：两例报告
BMC Pulm Med. 2020 Nov 23;20(1):308. doi: 10.1186/s12890-020-01348-8.
引用本文的文献
1
Rate and Risk Factors of Reinfection, Recurrence, and Hospital Readmission Among SARS-Cov-2 Hospitalized Patients; a National Cohort Study.新冠病毒住院患者再次感染、复发及再次入院的发生率和危险因素；一项全国队列研究。
Arch Acad Emerg Med. 2024 Jun 22;12(1):e55. doi: 10.22037/aaem.v12i1.2327. eCollection 2024.
2
An update on SARS-CoV-2 immunization and future directions.新型冠状病毒2型免疫接种的最新情况及未来方向。
Front Pharmacol. 2023 Mar 9;14:1125305. doi: 10.3389/fphar.2023.1125305. eCollection 2023.
3
Evaluation of possible COVID-19 reinfection in children: A multicenter clinical study.评估儿童中可能的 COVID-19 再感染：一项多中心临床研究。
Arch Pediatr. 2023 Apr;30(3):187-191. doi: 10.1016/j.arcped.2023.01.008. Epub 2023 Feb 7.
4
Reinfection with SARS-CoV-2 in a patient undergoing chemotherapy for lymphoma: Case report.一名正在接受淋巴瘤化疗的患者再次感染严重急性呼吸综合征冠状病毒2：病例报告。
J Assoc Med Microbiol Infect Dis Can. 2022 Sep 27;7(3):283-291. doi: 10.3138/jammi-2021-0036. eCollection 2022 Sep.
5
Microbiological and Clinical Findings of SARS-CoV-2 Infection after 2 Years of Pandemic: From Lung to Gut Microbiota.大流行两年后新型冠状病毒感染的微生物学和临床发现：从肺部到肠道微生物群
Diagnostics (Basel). 2022 Sep 2;12(9):2143. doi: 10.3390/diagnostics12092143.
6
Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review.新冠病毒二次感染患者的临床和流行病学特征：一项系统综述
New Microbes New Infect. 2022 Jul;48:101021. doi: 10.1016/j.nmni.2022.101021. Epub 2022 Aug 28.
7
Clinical manifestations, treatment options, and comorbidities in COVID-19 relapse patients: A systematic review.COVID-19 复发患者的临床表现、治疗选择和合并症：系统评价。
J Clin Lab Anal. 2022 May;36(5):e24402. doi: 10.1002/jcla.24402. Epub 2022 Apr 8.
8
SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature.SARS-CoV-2 再次感染对全球疫苗接种运动的效果构成新挑战：对文献报告病例的系统评价。
Int J Environ Res Public Health. 2021 Oct 19;18(20):11001. doi: 10.3390/ijerph182011001.
9
Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID-19: A systematic review and meta-analysis.COVID-19 再感染、复发和住院病例的流行病学特征：系统评价和荟萃分析。
J Med Virol. 2022 Jan;94(1):44-53. doi: 10.1002/jmv.27281. Epub 2021 Aug 27.
本文引用的文献
1
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.人类感染 SARS-CoV-2 后三个月内中和抗体反应的纵向观察和下降。
Nat Microbiol. 2020 Dec;5(12):1598-1607. doi: 10.1038/s41564-020-00813-8. Epub 2020 Oct 26.
2
Genomic evidence for reinfection with SARS-CoV-2: a case study.基因组证据表明 SARS-CoV-2 再次感染：一项案例研究。
Lancet Infect Dis. 2021 Jan;21(1):52-58. doi: 10.1016/S1473-3099(20)30764-7. Epub 2020 Oct 12.
3
Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct Strain.一株系统发育上不同的毒株导致的有症状的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）再次感染
Clin Infect Dis. 2021 Jul 15;73(2):354-356. doi: 10.1093/cid/ciaa1330.
4
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.疾病严重程度决定了 COVID-19 患者体内 SARS-CoV-2 特异性中和抗体反应。
Signal Transduct Target Ther. 2020 Sep 2;5(1):180. doi: 10.1038/s41392-020-00301-9.
5
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing.2019 年冠状病毒病（COVID-19）通过全基因组测序确认为与严重急性呼吸综合征冠状病毒 2 株系不同的病毒再次感染。
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951. doi: 10.1093/cid/ciaa1275.
6
Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020.2020 年 1 月至 5 月期间，英国 COVID-19 病例的传染性持续时间及其与 RT-PCR 循环阈值的相关性。
Euro Surveill. 2020 Aug;25(32). doi: 10.2807/1560-7917.ES.2020.25.32.2001483.
7
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?新冠康复后临床复发的 COVID-19 症状：病毒复发、再感染还是炎症反弹？
J Infect. 2020 Nov;81(5):816-846. doi: 10.1016/j.jinf.2020.06.073. Epub 2020 Jun 30.
Zotero 插件